Clinical Trial Update: a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating a new treatment for newly diagnosed IDH1-mutant acute myeloid leukemia and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tibsovo (ivosidenib)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, IDH1 Gene Mutation | Phase 2 | Status: RECRUITING